Canon U.S.A. announced Thursday it has made a strategic investment in Ottawa-based Spartan Bioscience Inc. to fund research and development of new diagnostic testing products.
Canon’s wholly-owned subsidiary, Canon BioMedical Inc. is looking into ways it can work with Spartan on other products like rapid genetic testing.
“We are excited to continue our efforts as we move into new markets for rapid genetic testing,” Spartan CEO Paul Lem said in a statement. “Working with Canon will help accelerate our progress in the future.”
OBJ360 (Sponsored)
Glenview Homes Unveils Union West: A New Chapter in Stittsville Living
Union West, Glenview Homes’ highly anticipated new community in the heart of Stittsville is welcoming buyers at its brand-new Sales Centre and model home, The Reveli, located at 6147 Fernbank
Esmee Bennison says she wasn’t sure what she wanted to do with her life back in Grade 11, when she enroled in a technological design class at uOttawa. She had
Seymour Liebman, who currently sits on Canon BioMedical’s board of directors will also join Spartan’s board.
“Spartan’s goals align with our mission to provide enhanced diagnostic testing systems that can help improve human health worldwide,” Mr. Liebman said in a statement.
Terms of the investment were not disclosed.
